Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Lexaria Bioscience Corp (LXX.CN)

Lexaria Bioscience Corp (LXX.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 34,520
  • Shares Outstanding, K 80,721
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta 2.05
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 12.65
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.05
  • Most Recent Earnings -0.01 on 02/29/20
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.320 +31.25%
on 03/18/20
0.580 -27.59%
on 03/19/20
-0.110 (-20.75%)
since 03/06/20
3-Month
0.320 +31.25%
on 03/18/20
0.750 -44.00%
on 01/23/20
-0.040 (-8.70%)
since 01/07/20
52-Week
0.320 +31.25%
on 03/18/20
1.590 -73.58%
on 04/17/19
-1.130 (-72.90%)
since 04/05/19

Most Recent Stories

More News
Lexaria Bioscience Corp. to Webcast Live at Life Sciences Investor Forum March 26

Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platform today announced that Chris Bunka, Chief Executive Officer, will present live...

LXRP : 0.2916 (-2.80%)
LXX.CN : 0.420 (unch)
Virtual Conference for Life Sciences Companies and Investors Broadcast Live March 26, 2020

Life Sciences Investor Forum today announced the agenda for its inaugural event for public and private companies, investors and industry professionals from around the world. This day-long virtual event...

LXX.CN : 0.420 (unch)
Lexaria Bioscience Expands Pharmaceutical Division to Include Lipophilic Antiviral Active Molecules for COVID-19 Treatment

(via TheNewswire)

LXRP : 0.2916 (-2.80%)
LXX.CN : 0.420 (unch)
Lexaria Bioscience Begins Coronavirus COVID-19 Drug Delivery Program

KELOWNA, BC / ACCESSWIRE / March 19, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery technology, announces it is commencing a program,...

LXRP : 0.2916 (-2.80%)
LXX.CN : 0.420 (unch)
Lexaria Bioscience Announces Warrant Issuance

(via TheNewswire)

LXRP : 0.2916 (-2.80%)
LXX.CN : 0.420 (unch)
Marijuana Market : Industry Outlook By Drivers, Restraints And 2017-2025

Global Marijuana Market was valued at USD 17.2 Billion in the year 2017. Global Marijuana Market is further estimated to grow at a CAGR of 22.9% from 2019 to reach USD 88.97 Billion by the year 2025. North...

ACB.TO : 1.12 (unch)
CBDS : 0.6300 (-3.08%)
CGRW : 0.0490 (-2.00%)
GRNH : 0.0032 (+10.34%)
LXX.CN : 0.420 (unch)
MJNA : 0.0148 (unch)
CNAB : 0.0575 (-4.17%)
Lexaria Provides Update on Two Licensed Clients

KELOWNA, British Columbia / ACCESSWIRE / March 4, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that it has...

LXRP : 0.2916 (-2.80%)
LXX.CN : 0.420 (unch)
Industry Solutions from Lexaria's DehydraTECHTM Hemp and Cannabis Powders

KELOWNA, BC / ACCESSWIRE / February 13, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that its DehydraTECHTM-enabled...

LXRP : 0.2916 (-2.80%)
LXX.CN : 0.420 (unch)
Lexaria Awards Options

(via TheNewswire)

LXRP : 0.2916 (-2.80%)
LXX.CN : 0.420 (unch)
Lexaria Bioscience Corp. and Cannadips Cannabis Announce Expanded Relationship Into Cannabis Oral Pouch & Dip Category

KELOWNA, BC / ACCESSWIRE / January 22, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that it has reached a...

LXRP : 0.2916 (-2.80%)
LXX.CN : 0.420 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

2nd Resistance Point 0.560
1st Resistance Point 0.490
Last Price 0.420
1st Support Level 0.340
2nd Support Level 0.260

See More

52-Week High 1.590
Fibonacci 61.8% 1.105
Fibonacci 50% 0.955
Fibonacci 38.2% 0.805
Last Price 0.420
52-Week Low 0.320

See More

Business Summary

Lexaria Bioscience Corp is a food science company. The company's food sciences activities include the development of the proprietary nutrient infusion technologies for the production of superfoods, and the production of enhanced food products under two consumer product brands, ViPova and Lexaria Energy....

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar